Related Experiment Video
Updated: Mar 31, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study
Stina Jakobsson1, Anna-Lotta Irewall2, Fredrik Bjorklund3
1Department of Public Health and Clinical Medicine, Division of Medicine, Ostersund sjukhus, Umea University, Umea, Sweden. stina.jakobsson@umu.se.
Insights
Nurse-based telephone follow-up significantly improved low-density lipoprotein cholesterol (LDL-C) levels in high-risk patients with diabetes mellitus (DM) or chronic kidney disease (CKD) 12 months post-discharge.
Area of Science:
- Cardiovascular Medicine
- Clinical Trials
- Health Services Research
Background:
- Enhanced cardiovascular secondary preventive follow-up is crucial for improving adherence to recommended low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP) levels.
- Patients with diabetes mellitus (DM) or chronic kidney disease (CKD) face elevated risks of recurrent cardiovascular events, necessitating effective secondary prevention strategies.
Purpose of the Study:
- To evaluate the effectiveness of nurse-based telephone follow-up compared to usual care in improving LDL-C and BP levels in patients post-acute coronary syndrome, stroke, or transient ischemic attack.
Main Methods:
- Randomized controlled trial involving patients with DM or CKD after acute coronary syndrome, stroke, or transient ischemic attack.
- Intervention group received nurse-based telephone follow-up with medication titration; control group received usual care.
- LDL-C and BP were measured at baseline (1 month) and 12 months post-discharge.
Main Results:
- Among patients with above-target baseline LDL-C, 52.3% in the intervention group achieved target levels at 12 months versus 21.3% in the control group (p < 0.001).
- Median systolic BP (SBP) at 12 months was 140 mmHg for the intervention group and 145 mmHg for the control group (p = 0.26).
- A non-significant trend showed more intervention patients reaching target SBP (49.4% vs. 36.8%).
Conclusions:
- Nurse-based telephone follow-up is a more effective strategy than usual care for improving LDL-C levels in high-risk patients with DM or CKD 12 months post-discharge.
- The intervention showed a positive trend in improving SBP, warranting further investigation.
Background:
Enhanced cardiovascular secondary preventive follow-up is needed to improve adherence to recommended low-density lipoprotein cholesterol (LDL-C) and blood pressure (BP) levels. Patients with diabetes mellitus (DM) or chronic kidney disease (CKD) have a high risk of recurrent events. Secondary prevention is therefore essential in these patients.
Methods:
Patients with acute coronary syndrome, stroke, or transient ischemic attack were randomized to nurse-based telephone follow-up (intervention) or usual care (control). LDL-C and BP were measured at 1 month (baseline) and 12 months post-discharge. Intervention patients with above-target values at baseline received medication titration to achieve treatment goals. Values measured for control patients were given to the patient's general practitioner for assessment.
Results:
The final analyses included 225 intervention and 215 control patients with DM or CKD. Among patients with above-target baseline values, the following 12-month values were recorded for intervention and control patients, respectively: LDL-C, 2.2 versus 3.0 mmol/L (p < 0.001); and median systolic BP (SBP), 140 versus 145 mmHg (p = 0.26). Among patients with above-target values at baseline, 52.3 % of intervention patients reached target LDL-C values at 12 months versus 21.3 % of control patients (absolute difference of 30.9 %, 95 % CI 16.1 to 43.8 %), and there was a non-significant trend of more intervention patients reaching target SBP (49.4 % versus 36.8 %; absolute difference of 12.6 %, 95 % CI -1.7 to 26.2 %).
Conclusions:
Cardiovascular secondary prevention with nurse-based telephone follow-up was more effective than usual care in improving LDL-C levels 12 months after discharge for patients with DM or CKD.
Trial Registration:
ISRCTN registry; ISRCTN96595458 (date of registration 10 July 2011) and ISRCTN23868518 (date of registration 13 May 2012).
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Hypertension IV: Drug Therapy and Lifestyle Modifications
